Novartis | Beneficio Operativo



Operating Profit Cambio Fecha
AbbVie USD 3.73B 5.22B 2025-03
Alcon AG USD 395M 63M 2024-12
Almirall EUR 53.03M 68.53M 2024-06
Amgen USD 1.29B 1.02B 2025-03
AstraZeneca USD 3.67B 1.64B 2025-03
Autolus Therapeutics Ltd -75864000 7.99M 2024-12
Bayer EUR 3.53B 7.35B 2024-12
Biogen USD 311.2M 130.2M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Fresenius EUR 687M 218M 2025-03
Fresenius Medical Care EUR 331M 72.1M 2025-03
Galapagos EUR -158708000 95.99M 2025-03
Genmab DKK 2.19B 89M 2024-12
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
GRIFOLS EUR 371.86M 54.83M 2024-12
Hikma Pharmaceutical USD 327M 208M 2024-06
J&J USD 13.63B 9.74B 2025-03
Lonza CHF 534M 194M 2024-06
Merck EUR 1.2B 100M 2024-12
Merck USD 5.87B 1.57B 2025-03
Novartis USD 2.28B 1.34B 2024-12
Novartis USD 3.4B 193M 2024-12
Novo Nordisk 38.79B 4.97B 2025-03
Orion EUR 77.9M 14.8M 2025-03
Pfizer USD 3.67B 4.08B 2025-03
Philips EUR 154M 45M 2025-03
Recordati EUR 162.68M 13.82M 2024-09
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 2.28B 1.42B 2025-03
UCB EUR 163M 39M 2024-06



Novartis Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.